| Nuwellis, Inc. Announces First Quarter 2026 Financial Results |
Globe Newswire |
05/12 |
08:00 |
| Octave Launches Reliance™ Advanced Manufacturing Package, a QMS that Addresses Rising Product Complexity |
Globe Newswire |
05/12 |
08:00 |
| Artios Announces Clinical Trial Collaboration with GSK to Evaluate Alnodesertib in Combination with Risvutatug Rezetecan, a B7-H3-Targeted ADC in Gastrointestinal Tumors |
Globe Newswire |
05/12 |
08:00 |
| Rocket Doctor and University of Toronto Launch Digital Health Observership Program for Physician Assistant Students |
Globe Newswire |
05/12 |
08:00 |
| Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update |
Globe Newswire |
05/12 |
08:00 |
| Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology |
Globe Newswire |
05/12 |
08:00 |
| Kalaris Reports First Quarter 2026 Financial Results and Provides Business Updates |
Globe Newswire |
05/12 |
08:00 |
| Genius Group Releases Updates on AI Education and Digital Banking Plans |
Globe Newswire |
05/12 |
08:00 |
| Biometric Identity and Authentication Provider BIO-key to host Q1’26 Investor Webcast Monday, May 18th at 10am ET |
Globe Newswire |
05/12 |
07:59 |
| FX Junction Releases Report on Top 5 Cases of Social Media Impact on Stock Markets |
Globe Newswire |
05/12 |
07:58 |
| ZenaTech Targets Gulf State Defense Markets with Lviv-Based Phoenix Aero Counter-UAS and Interceptor Drone Production |
Globe Newswire |
05/12 |
07:45 |
| Crypto News Today:AI GPU RENTAL Enables AI-Driven Infrastructure Access Bitcoin Price Expected to Reach $310,000 |
Globe Newswire |
05/12 |
07:45 |
| MiNK Therapeutics Presents Clinical Evidence That a Single, Off-the-Shelf, iNKT Cell Product Drives Context-Dependent Immune Responses at ASGCT 2026 |
Globe Newswire |
05/12 |
07:35 |
| Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics |
Globe Newswire |
05/12 |
07:31 |
| Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates |
Globe Newswire |
05/12 |
07:30 |
| BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients |
Globe Newswire |
05/12 |
07:30 |
| Vireo Growth Inc. Announces First Quarter 2026 Results |
Globe Newswire |
05/12 |
07:30 |
| Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates |
Globe Newswire |
05/12 |
07:30 |
| Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates |
Globe Newswire |
05/12 |
07:30 |
| Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference |
Globe Newswire |
05/12 |
07:30 |
| Compass Therapeutics to Participate in Upcoming May Investor Events |
Globe Newswire |
05/12 |
07:30 |
| Harvard Bioscience Announces First Quarter 2026 Financial Results |
Globe Newswire |
05/12 |
07:30 |
| SAB BIO Reports Q1 2026 Financial Results and Recent Business Highlights |
Globe Newswire |
05/12 |
07:30 |
| BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1 |
Globe Newswire |
05/12 |
07:30 |
| Nayax Reports First Quarter 2026 Results |
Globe Newswire |
05/12 |
07:30 |
